(Q55055409)

16 June 2018

title

Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. (English)

1 reference

16 June 2018

1 reference

Kristel Kodar

1

1 reference

16 June 2018

Johannes Stadlmann

2

1 reference

16 June 2018

Kersti Klaamas

3

1 reference

16 June 2018

Boris Sergeyev

4

1 reference

16 June 2018

Oleg Kurtenkov

5

1 reference

16 June 2018

publication date

17 December 2011

1 reference

16 June 2018

published in

Glycoconjugate Journal

1 reference

16 June 2018

volume

29

1 reference

16 June 2018

issue

1

1 reference

16 June 2018

page(s)

57-66

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/s10719-011-9364-z

exact match

0 references

cites work

Biological significance of carbohydrate chains on monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Paradoxical behavior of asymmetric IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

N-glycosylation of serum proteins in disease and its investigation using lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Agalactosyl glycoforms of IgG autoantibodies are pathogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-011-9364-Z

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

21 January 2018

1 reference

12 December 2020

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

1 reference

12 December 2020

The impact of glycosylation on the biological function and structure of human immunoglobulins.

1 reference

12 December 2020

Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity

1 reference

12 December 2020

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

1 reference

12 December 2020

Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies

1 reference

12 December 2020

Data pre-processing in liquid chromatography-mass spectrometry-based proteomics

1 reference

12 December 2020

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations

1 reference

12 December 2020

Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

1 reference

12 December 2020

Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals

1 reference

12 December 2020

Analytical and Functional Aspects of Antibody Sialylation.

1 reference

12 December 2020

Analyzing antibody-Fc-receptor interactions

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer

1 reference

12 December 2020

Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival

1 reference

12 December 2020

Structure and function of immunoglobulins

1 reference

12 December 2020

Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides

1 reference

12 December 2020

Hypogalactosylation of salivary and gingival fluid immunoglobulin G in patients with advanced periodontitis

1 reference

12 December 2020

Changes in serum IgG oligosaccharide chains with prostate cancer progression.

1 reference

12 December 2020

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

1 reference

12 December 2020

Role of chemokines in tumor growth

1 reference

12 December 2020

Glycosylation defining cancer malignancy: new wine in an old bottle

1 reference

12 December 2020

N-glycosylation of plant recombinant pharmaceuticals

1 reference

12 December 2020

Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms

1 reference

12 December 2020

Aberrant glycosylation of Igg heavy chain in multiple myeloma

1 reference

12 December 2020

A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine

1 reference

12 December 2020

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

1 reference

12 December 2020

Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors--relation to Lewis (a,b) histo-blood group phenotype

1 reference

12 December 2020

The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients

1 reference

12 December 2020

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

1 reference

12 December 2020

Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins.

1 reference

12 December 2020

A close look at human IgG sialylation and subclass distribution after lectin fractionation

1 reference

12 December 2020

IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

1 reference

12 December 2020

IgG glycosylation analysis

1 reference

12 December 2020

IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab

1 reference

12 December 2020

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

12 December 2020

Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity

1 reference

12 December 2020

An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA)

1 reference

12 December 2020

10.1007/S10719-011-9364-Z

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

1046347858

0 references

1 reference

16 June 2018